AG
IMGN

Algert Global’s Immunogen Inc IMGN Stock Holding History

Algert Global’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-180,317
Closed -$2.86M – 1306
2023
Q3 		$2.86M Buy
+180,317
New +$3M 0.13% 249
2022
Q3 		– Sell
-162,237
Closed -$730K – 1381
2022
Q2 		$730K Sell
162,237
-87,360
-35% -$380K 0.05% 607
2022
Q1 		$1.19M Buy
249,597
+221,354
+784% +$1.23M 0.08% 446
2021
Q4 		$210K Hold
28,243
– – 0.03% 840
2021
Q3 		$160K Buy
+28,243
New +$163K 0.02% 936
2015
Q2 		– Sell
-18,120
Closed -$162K – 372
2015
Q1 		$162K Buy
+18,120
New +$131K 0.09% 285
2014
Q2 		– Sell
-18,320
Closed -$274K – 353
2014
Q1 		$274K Buy
+18,320
New +$289K 0.11% 246

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Algert Global's IMGN Position: Q4 2023 in Review

Algert Global sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 180,317 shares — an estimated $2.86M sold.

Algert Global first reported a position in IMGN in Q1 2014 and held it in 7 quarters. The position peaked at $2.86M in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Algert Global reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Algert Global sold 180,317 Immunogen Inc shares in Q4 2023, an estimated $2.86M.
  • Algert Global first reported a position in Immunogen Inc in Q1 2014 and held it in 7 quarters.
  • Algert Global's Immunogen Inc position peaked at $2.86M in Q3 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Algert Global's 13F filing for Q4 2023, filed 14 Feb 2024.